– April 24, 2019
Earlier this month, the FDA granted accelerated approval to Johnson & Johnson’s new bladder cancer drug, even as the company deals with the fallout from asbestos-containing talc and surgical mesh.
The drug, Balversa, was approved based on a small study of just 87 patients and will cost up to $5,670 per week.
This is fortunate timing for Johnson & Johnson – and their investors – and presents an opportunity for billions in new revenue. But as the company faces thousands of lawsuits from customers who have been injured or killed by their products, it’s easy to wonder if Johnson & Johnson and their friends at the FDA are more interested in profit than cancer patients.
Let’s take a look at the darker side of Johnson & Johnson, the people who have been hurt by their lies, and the truth behind their new cancer treatment.
Read more via FDA Rewards Johnson & Johnson’s Lies with… — The Truth About Cancer
Alex Pietrowski, Staff Writer Waking Times A physician’s word is often taken very seriously and with little skepticism. An opinion from one or two doctors, when made in a professional office or hospital, can persuade a worried patient to take drugs with complex side-effects, or even undergo traumatic treatments such as radiation and chemotherapy. Yet, when the…..Read more
via Esteemed Heart Surgeon Blows the Lid Off the Big Pharma Statin Drug Scam — Waking Times
By B.N. Frank Activist Post and sister publication, Natural Blaze, have already published many articles about the ongoing nightmare that is being marketed as the “Race for 5G.” Never heard of this? It involves installing millions of 4G and 5G small cell towers and related wireless infrastructure pretty much everywhere – including in front of…Read more, videos & sign petition
via International Appeal and Petition: Stop 5G on Earth and in Space —
Stop 5G on Earth and in Space